AI-generated summary
The authors compared 52 patients who received intravascular 808-nm low-power laser illumination after coronary angioplasty with 49 control patients. They report that the restenosis rate difference was not significant (15.0% vs 32.4%), though minimal lumen diameter and late lumen loss favored the laser group. The authors conclude the therapy seemed effective and safe, but this is a small, single-center comparison with no randomization reported.
- Who or what was studied
- Patients undergoing percutaneous coronary angioplasty, 52 in the laser group and 49 in the control group
- Wavelengths
- 808 nm
- Limits stated in the abstract
- The restenosis rate difference was not statistically significant, and the abstract describes a small non-randomized comparison with 6- and 12-month follow-up only.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on linkinghub.elsevier.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Laser, Control group. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.